/
/
/

Medico Remedies Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
₹69 Cr₹57 Cr₹59 Cr₹53 Cr₹38 Cr₹41 Cr₹39 Cr₹39 Cr₹31 Cr₹41 Cr₹30 Cr₹42 Cr₹31 Cr₹28 Cr₹39 Cr₹40 Cr₹33 Cr₹32 Cr₹30 Cr₹30 Cr₹29 Cr
₹1 Cr₹3 Cr₹68 L₹2 Cr₹66 L₹29 L₹1 Cr₹68 L₹29 L₹58 L₹27 L₹96 L₹31 L₹4 L₹86 L₹2 Cr₹2 Cr₹74 L₹23 L₹80 L₹26 L
₹71 Cr₹60 Cr₹59 Cr₹54 Cr₹39 Cr₹42 Cr₹41 Cr₹40 Cr₹31 Cr₹42 Cr₹30 Cr₹43 Cr₹32 Cr₹28 Cr₹40 Cr₹42 Cr₹35 Cr₹33 Cr₹30 Cr₹30 Cr₹29 Cr
₹67 Cr₹50 Cr₹55 Cr₹51 Cr₹36 Cr₹35 Cr₹37 Cr₹38 Cr₹29 Cr₹37 Cr₹28 Cr₹40 Cr₹30 Cr₹26 Cr₹36 Cr₹38 Cr₹34 Cr₹31 Cr₹29 Cr₹28 Cr₹29 Cr
₹4 Cr₹10 Cr₹5 Cr₹4 Cr₹3 Cr₹7 Cr₹5 Cr₹3 Cr₹3 Cr₹5 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹4 Cr₹5 Cr₹1 Cr₹3 Cr₹2 Cr₹3 Cr₹87 L
₹41 L₹90 L₹39 L₹24 L₹28 L₹49 L₹28 L₹21 L₹18 L₹25 L₹22 L₹18 L₹17 L₹21 L₹20 L₹17 L₹17 L₹13 L₹20 L₹17 L₹16 L
₹3 Cr₹8 Cr₹4 Cr₹3 Cr₹2 Cr₹6 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹65 L₹2 Cr₹2 Cr₹2 Cr₹28 L
₹3 Cr₹6 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹36 L₹2 Cr₹1 Cr₹2 Cr₹14 L

Share Price Live Stats

Open (₹)39.40
Volume (₹)25,562.00
High (₹)39.91
Upper Circuit47.40
Low (₹)39.00
Lower Circuit31.60
Prev Close39.50
52W High (₹)56.88
Price39.29
52W Low (₹)30.22

Share Market Cap & Key Ratios Overview

M.Cap (₹)328.45 Cr
Div. Yield (%)0.00
PE Ratio23.77
Debt to Equity0.22
Price to Book6.92
Book Value7.53
EPS (TTM)1.66
Face Value2.00
ROE (%)17.58

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
MEDICONSE
LTP
1W Low
1W High
Market cap (₹)
1905.1-14.9 (-0.78%)
1902
1984.80
4,56,833Cr
9211.5-27.5 (-0.30%)
9087
9467
2,45,426Cr
4894-156 (-3.09%)
4885
5066
1,87,320Cr
1133.2-57.8 (-4.85%)
1125.10
1187
1,13,217Cr
1391.5-32 (-2.25%)
1376.70
1426.10
1,12,212Cr
1854.2-84.3 (-4.35%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2349.2-33.7 (-1.41%)
2341.20
2419.20
96,859Cr
1163.9-14.1 (-1.20%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
39.29-3.12 (-7.36%)
36.90
43
328Cr

Key Highlights of Medico Remedies Ltd’s P&L

In 2025-03-31, Medico Remedies Ltd reported total revenue of ₹150.94Cr, compared with ₹144.92Cr in 2024-03-31, reflecting Medico Remedies Ltd turnover.

Depreciation was ₹3.03Cr and finance costs were ₹1.16Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹13.5Cr in 2025-03-31 as compared to ₹11.33Cr in 2024-03-31.

Net Profit (PAT) was ₹10.09Cr in 2025-03-31 compared with ₹8.29Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.22 in 2025-03-31, compared with ₹1 in 2024-03-31.